Published in Protein Sci on March 01, 2003
NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics (2008) 3.59
One-pot, mix-and-read peptide-MHC tetramers. PLoS One (2008) 1.50
Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture. Curr Protoc Immunol (2013) 1.24
Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. J Immunol Methods (2010) 1.18
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res (2009) 1.03
The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype. Immunogenetics (2008) 0.97
Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule. J Immunol (2014) 0.97
Porcine major histocompatibility complex (MHC) class I molecules and analysis of their peptide-binding specificities. Immunogenetics (2011) 0.91
MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides. PLoS One (2013) 0.83
A novel system for continuous protein refolding and on-line capture by expanded bed adsorption. Protein Sci (2005) 0.81
A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01. Immunogenetics (2015) 0.81
Use of "one-pot, mix-and-read" peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle. Vet Res (2014) 0.80
Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery. Immunogenetics (2014) 0.79
Tapasin discriminates peptide-human leukocyte antigen-A*02:01 complexes formed with natural ligands. J Biol Chem (2011) 0.77
Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.75
Recombinant chymosin used for exact and complete removal of a prochymosin derived fusion tag releasing intact native target protein. Protein Sci (2009) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (1991) 13.90
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A (1992) 5.02
The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem J (1986) 3.22
In vitro folding of inclusion body proteins. FASEB J (1996) 2.40
Effects of macromolecular crowding on protein folding and aggregation. EMBO J (1999) 2.15
Definition of specific peptide motifs for four major HLA-A alleles. J Immunol (1994) 2.11
Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity (2002) 1.76
Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction. Tissue Antigens (2002) 1.68
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc Natl Acad Sci U S A (1993) 1.30
Examination of calf prochymosin accumulation in Escherichia coli: disulphide linkages are a structural component of prochymosin-containing inclusion bodies. EMBO J (1985) 1.22
Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method. Biochim Biophys Acta (1995) 1.22
Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds. Eur J Immunol (2001) 1.19
Submit and disulfide structure of monomeric and dimeric forms of detergent-soluble HLA antigens. J Biol Chem (1977) 1.18
Intracellular surveillance: controlling the assembly of MHC class I-peptide complexes. Traffic (2000) 1.10
pH dependence of MHC class I-restricted peptide presentation. J Immunol (1996) 0.96
Disulfide bond formation and folding of plant peroxidases expressed as inclusion body protein in Escherichia coli thioredoxin reductase negative strains. Protein Expr Purif (1999) 0.89
Description and prediction of peptide-MHC binding: the 'human MHC project'. Curr Opin Immunol (1999) 0.89
Beta 2-microglobulin and calnexin can independently promote folding and disulfide bond formation in class I histocompatibility proteins. Mol Immunol (1997) 0.88
Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin. Mol Immunol (1995) 0.87
Removal of chromosomal DNA by Mg2+ in the lysis buffer: an improved lysis protocol for preparing Escherichia coli whole-cell lysates for sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem (1997) 0.86
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci (2003) 5.94
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res (2008) 4.53
Bioinformatics training: a review of challenges, actions and support requirements. Brief Bioinform (2010) 4.02
NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One (2007) 3.99
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics (2004) 3.72
NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics (2008) 3.59
Bioinformatics Training Network (BTN): a community resource for bioinformatics trainers. Brief Bioinform (2011) 2.79
Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol (2008) 2.48
Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics (2004) 2.39
An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol (2005) 2.19
Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol (2006) 2.11
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol (2009) 1.83
NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res (2010) 1.78
MHC class II epitope predictive algorithms. Immunology (2010) 1.72
CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine (2006) 1.66
One-pot, mix-and-read peptide-MHC tetramers. PLoS One (2008) 1.50
NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics (2013) 1.49
Best practices in bioinformatics training for life scientists. Brief Bioinform (2013) 1.45
HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control. J Virol (2011) 1.31
Identification and characterization of a novel thioredoxin-related transmembrane protein of the endoplasmic reticulum. J Biol Chem (2004) 1.29
Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays. J Biomol Screen (2009) 1.27
Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells. J Virol (2010) 1.26
Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity. Eur J Immunol (2012) 1.24
HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J Immunol (2008) 1.24
Protein purification using magnetic adsorbent particles. Appl Microbiol Biotechnol (2006) 1.24
Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology (2010) 1.21
NNAlign: a web-based prediction method allowing non-expert end-user discovery of sequence motifs in quantitative peptide data. PLoS One (2011) 1.20
HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703. J Immunol (2011) 1.18
Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. J Immunol Methods (2010) 1.18
Predicting proteasomal cleavage sites: a comparison of available methods. Int Immunol (2003) 1.12
HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides. Immunogenetics (2010) 1.11
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res (2009) 1.03
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study. Cancer Immunol Immunother (2004) 1.02
Surfactant-free purification of membrane proteins with intact native membrane environment. Biochem Soc Trans (2011) 1.01
MHCcluster, a method for functional clustering of MHC molecules. Immunogenetics (2013) 1.01
HIV control through a single nucleotide on the HLA-B locus. J Virol (2012) 1.00
Discovering naturally processed antigenic determinants that confer protective T cell immunity. J Clin Invest (2013) 0.99
Nef-specific CD8+ T cell responses contribute to HIV-1 immune control. PLoS One (2013) 0.98
Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. J Gen Virol (2003) 0.98
iAnn: an event sharing platform for the life sciences. Bioinformatics (2013) 0.96
High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide. Acta Crystallogr D Biol Crystallogr (2005) 0.95
Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype. Acta Crystallogr D Biol Crystallogr (2006) 0.94
Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength. PLoS One (2011) 0.94
Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues. FEBS J (2008) 0.94
Perceptual weights in auditory level discrimination. J Acoust Soc Am (2003) 0.93
NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery. Immunology (2014) 0.93
Genome-based in silico identification of new Mycobacterium tuberculosis antigens activating polyfunctional CD8+ T cells in human tuberculosis. J Immunol (2010) 0.93
A strategy for bacterial production of a soluble functional human neonatal Fc receptor. J Immunol Methods (2007) 0.92
Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach. Neural Comput (2003) 0.92
Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Immunogenetics (2014) 0.91
A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape. Retrovirology (2015) 0.90
The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling. Cancer Lett (2006) 0.90
Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response. PLoS One (2012) 0.90
Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL. PLoS One (2010) 0.89
Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy. J Immunol (2013) 0.89
Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope. J Virol (2012) 0.89
Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC. Cell Immunol (2003) 0.88
Loudness enhancement: induced loudness reduction in disguise? (L). J Acoust Soc Am (2002) 0.88
Structure-function analysis of the endoplasmic reticulum oxidoreductase TMX3 reveals interdomain stabilization of the N-terminal redox-active domain. J Biol Chem (2007) 0.86
Spectral loudness summation and simple reaction time. J Acoust Soc Am (2004) 0.86
Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions. BMC Bioinformatics (2014) 0.85
Wildtype p53-specific antibody and T-cell responses in cancer patients. J Immunother (2011) 0.85
Changes in protein expression in p53 deleted spontaneous thymic lymphomas. Exp Cell Res (2004) 0.85
Solid-supported enzymatic synthesis of pectic oligogalacturonides and their analysis by MALDI-TOF mass spectrometry. Carbohydr Res (2003) 0.85
HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses. PLoS One (2010) 0.85
The outermost N-terminal region of tapasin facilitates folding of major histocompatibility complex class I. Eur J Immunol (2009) 0.85
HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01. J Virol (2013) 0.85
Soluble human leukocyte antigen-G in seminal plasma is associated with HLA-G genotype: possible implications for fertility success. Am J Reprod Immunol (2014) 0.85
Oriented coupling of major histocompatibility complex (MHC) to sensor surfaces using light assisted immobilisation technology. Biosens Bioelectron (2005) 0.83
Use of laminar flow patterning for miniaturised biochemical assays. Lab Chip (2004) 0.83
A comparison of psychophysical procedures for level-discrimination thresholds. J Acoust Soc Am (2003) 0.83
Tapasin facilitation of natural HLA-A and -B allomorphs is strongly influenced by peptide length, depends on stability, and separates closely related allomorphs. J Immunol (2013) 0.83
Clinical application of dendritic cells in cancer vaccination therapy. APMIS (2003) 0.83
MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides. PLoS One (2013) 0.83
Studies related to antibody fragment (Fab) production in Escherichia coli W3110 fed-batch fermentation processes using multiparameter flow cytometry. Cytometry A (2009) 0.83
Structure of Bacillus halmapalus alpha-amylase crystallized with and without the substrate analogue acarbose and maltose. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.82
Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides. Immunology (2011) 0.82
Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope. Cancer Immunol Immunother (2007) 0.81
A novel system for continuous protein refolding and on-line capture by expanded bed adsorption. Protein Sci (2005) 0.81
Lumped parameter model for prediction of initial breakthrough profiles for the chromatographic capture of antibodies from a complex feedstock. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.81
Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display. Sci Rep (2013) 0.81
Interactions between test- and inducer-tone durations in induced loudness reduction. J Acoust Soc Am (2003) 0.81
Immobilization of pectin fragments on solid supports: novel coupling by thiazolidine formation. Bioconjug Chem (2002) 0.81
Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.81
Incomplete effector/memory differentiation of antigen-primed CD8+ T cells in gene gun DNA-vaccinated mice. Eur J Immunol (2003) 0.80
Identification of conserved subdominant HIV Type 1 CD8(+) T Cell epitopes restricted within common HLA Supertypes for therapeutic HIV Type 1 vaccines. AIDS Res Hum Retroviruses (2012) 0.80
The effects of window delay, delinearization, and frequency on tone-burst otoacoustic emission input/output measurements. J Acoust Soc Am (2004) 0.80
Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes. PLoS One (2010) 0.80
HIV subtype influences HLA-B*07:02-associated HIV disease outcome. AIDS Res Hum Retroviruses (2013) 0.80